The results of this study showed that there were statistical differences in the numeric levels and proportion of six tumor markers, including SCC-Ag, CEA, CYFRA 21-1, NSE, CA199 and TPSA, among patients with different tumor stages of NSCLC. This evidence concerns the gene ENO2 and non-small cell lung carcinoma.